Droxidopa Impurity 18 | CAS 78603-91-5 - Request Quote
Droxidopa Impurity 18
| SZ CAT No: | SZ-D057019 |
| CAS No | 78603-91-5 |
| Mol.F. | C15H17NO |
| Mol.Wt. | 227.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Droxidopa Impurity 18 is chemically (S)-2-Amino-1,1-diphenylpropan-1-ol. Droxidopa Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Droxidopa Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Droxidopa.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 78603-91-5
Purchase 78603-91-5
Order 78603-91-5
Enquire 78603-91-5
price of 78603-91-5
78603-91-5 Supplier
78603-91-5 Manufacturer
78603-91-5 Exporter
buy high quality Droxidopa Impurity 18
Purchase Droxidopa Impurity 18
Droxidopa Impurity 18 suppliers
Droxidopa Impurity 18 manufacturers
Droxidopa Impurity 18 price
Order Droxidopa Impurity 18
Enquire Droxidopa Impurity 18
Droxidopa Impurity 18 cost
Droxidopa Impurity 18 Supplier
Droxidopa Impurity 18 Distributor
Droxidopa Impurity 18 for Method Validation
Droxidopa Reference Standard
Droxidopa Impurity 18 for ANDA Filing
Droxidopa Impurity 18 for Forced Degradation Studies
Droxidopa Impurity 18 Identification Standards
Droxidopa Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


